Condition : Rheumatoid Arthritis Interventions : Drug: rituximab [MabThera/Rituxan]; Drug: Methotrexate Sponsors : Hoffmann-La Roche; Hoffmann-La Roche Completed - verified September 2013

Condition : Rheumatoid Arthritis Intervention : Drug: rituximab [MabThera/Rituxan] Sponsors : Hoffmann-La Roche; Hoffmann-La Roche Completed - verified September 2013

Condition : Rheumatoid Arthritis Intervention : Drug: rituximab [MabThera/Rituxan] Sponsors : Hoffmann-La Roche; Hoffmann-La Roche Completed - verified September 2013

Condition : Rheumatoid Arthritis Interventions : Drug: rituximab [MabThera/Rituxan]; Drug: Methotrexate Sponsor : Hoffmann-La Roche Completed - verified July 2011

Condition : Rheumatoid Arthritis Intervention : Drug: rituximab [MabThera/Rituxan] Sponsor : Hoffmann-La Roche Active, not recruiting - verified July 2011

Condition : Rheumatoid Arthritis Intervention : Drug: Enbrel (etanercept) Sponsors : Pfizer; Pfizer Completed - verified September 2013

Condition : Rheumatoid Arthritis Intervention : Drug: Enbrel (etanercept) Sponsor : Pfizer Recruiting - verified August 2011

Condition : Osteoarthritis Intervention : Sponsor : Central Hospital, Nancy, France Completed - verified July 2007

Conditions : Osteoarthritis; Rheumatoid Arthritis Intervention : Behavioral: Exercise Sponsors : University of Alberta; Alberta Heritage Foundation for Medical Research; Canadian Institutes of Health...

Conditions : Pulmonary Hypertension; Connective Tissue Disease Intervention : Behavioral: exercise training Sponsor : University of Heidelberg Recruiting - verified May 2007